Embria Health Sciences has adopted EpiCor fermentate as a part of the American Botanical Council’s (ABC) Adopt-an-Herb Program. Through its adoption, Embria Health Sciences helps ABC expand its nonprofit educational mission and keep its unique HerbMedPro database updated with the latest scientific and clinical research on this new dietary ingredient. 

HerbMedPro is a comprehensive, interactive online database that provides access to important scientific and clinical research data on the uses and health effects of approximately 250 botanicals.

“As a science-based ingredient manufacturer, Embria is proud to have EpiCor fermentate be a part of the Adopt-an-Herb Program,” said Jeff Cannon, CEO of Diamond V, Embria’s parent company. “EpiCor, a unique immune and digestive support ingredient with years of human clinical research, brings a novel ingredient category to the HerbMedPro database. This partnership will help provide ABC’s audience of researchers and educators access to a wealth of vital research for addressing immune and gastrointestinal challenges.”

ABC Founder and Executive Director Mark Blumenthal thanked Embria Health Sciences for its support of ABC’s educational efforts and expressed his enthusiasm for the addition of a new ingredient to the database. “EpiCor has a unique story of discovery,” he said. “When Embria executives realized that workers who were exposed to the fermentation product in the company’s manufacturing facility made fewer claims for health care benefits than office workers who were not exposed, this led to the research and development of what became EpiCor: a unique example of a real-world observation that resulted in the creation of a new natural health-promoting ingredient.”

EpiCor fermentate is a safe and natural whole food fermentation ingredient that supports the immune and digestive systems. It is made using baker’s yeast (Saccharomyces cerevisiae) that goes through a proprietary fermentation process that yields a complex, nutrient-rich ingredient composed of immune-supporting metabolites, as well as proteins, vitamins, minerals, amino acids, polyphenols, and beta glucans. EpiCor is different from synthesized commodities such as nutritional yeast or isolated beta-glucan ingredients. More than 10 studies on EpiCor have been published, including eight human clinical trials and multiple safety studies.